iDNA Genomics Announces Extraordinary General Meeting
iDNA Genomics announced that it will hold an extraordinary general meeting of shareholders.
Related stories
Toggle Holdings Opens Below Its IPO Price
L impact | EQUITY | Oct 30, 2026, 12:14 AM UTC
ICE Publishes Q3 2026 Earnings Call Transcript
M impact | EQUITY | Oct 30, 2026, 12:14 AM UTC
Spectur Reports Q1 FY27 Revenue of A$1.47 Million
Q1 FY27 revenue included A$1.22 million in recurring revenue.
M impact | EQUITY | Oct 30, 2026, 12:12 AM UTC
StrategX Elements Raises $911,110.95 in Private Placement
StrategX Elements raised $911,110.95 in an oversubscribed private placement.
M impact | EQUITY | Oct 30, 2026, 12:12 AM UTC
Eli Lilly raises full-year revenue outlook on drug demand
Eli Lilly raised its full-year revenue outlook, citing stronger demand for obesity and diabetes drugs.
M impact | EQUITY | Oct 30, 2026, 12:11 AM UTC
SoftBank Group shares fall 5.7%
M impact | EQUITY | Oct 30, 2026, 12:09 AM UTC